In conclusion, our findings demonstrate a regulatory role for PD-L1+ B cells in RA patients in vitro and suggest that the PD-L1/PD-1 pathway may have a potential role in controlling disease activity since an increase in the frequency of these cells was associated with a positive response to treatment. The gene discussed is PDCD1; the disease is rheumatoid arthritis.